WA
SYRE icon

Waverly Advisors’s Spyre Therapeutics SYRE Stock Holding History

Waverly Advisors’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$291K Buy
19,453
+23
+0.1% +$344 ﹤0.01% 978
2025
Q1 		$314K Buy
+19,430
New +$314K ﹤0.01% 908